Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Biomarker Research
|
December 13, 2019
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
Isabelle Rouquette, Estelle Taranchon-Clermont, Julia Gilhodes, et al.
Virchows Archiv : an International Journal of Pathology
|
October 13, 2025
FOS gene fusions in osteosarcoma raise the hypothesis of malignant transformation of osteoblastoma
Christophe Bontoux, Marie Csanyi-Bastien, Corinne Bouvier, et al.
The American Journal of Surgical Pathology
|
August 2, 2021
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
Camille Laurent, José Adélaïde, Arnaud Guille, et al.
The Journal of Experimental Medicine
|
October 22, 2008
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
Marina Bousquet, Cathy Quelen, Roberto Rosati, et al.
Nature Communications
|
January 25, 2020
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
Caroline Imbert, Anne Montfort, Marine Fraisse, et al.
Haematologica
|
November 8, 2011
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Alejandra Carvajal-Cuenca, Luz F Sua, Nhora M Silva, et al.
Blood
|
February 26, 2026
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHL
Paul Marcoux, Fabien Gava, Marie Tosolini, et al.
Cancers
|
January 27, 2021
Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
Anne Gomez-Brouchet, Julia Gilhodes, Nathalie Van Acker, et al.
Blood
|
February 18, 2010
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study
Etienne Coyaud, Stephanie Struski, Nais Prade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2017
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Myron S Czuczman, Marek Trněný, Andrew Davies, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Biomarker Research
|
December 13, 2019
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
Isabelle Rouquette, Estelle Taranchon-Clermont, Julia Gilhodes, et al.
Virchows Archiv : an International Journal of Pathology
|
October 13, 2025
FOS gene fusions in osteosarcoma raise the hypothesis of malignant transformation of osteoblastoma
Christophe Bontoux, Marie Csanyi-Bastien, Corinne Bouvier, et al.
The American Journal of Surgical Pathology
|
August 2, 2021
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
Camille Laurent, José Adélaïde, Arnaud Guille, et al.
The Journal of Experimental Medicine
|
October 22, 2008
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
Marina Bousquet, Cathy Quelen, Roberto Rosati, et al.
Nature Communications
|
January 25, 2020
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
Caroline Imbert, Anne Montfort, Marine Fraisse, et al.
Haematologica
|
November 8, 2011
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Alejandra Carvajal-Cuenca, Luz F Sua, Nhora M Silva, et al.
Blood
|
February 26, 2026
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHL
Paul Marcoux, Fabien Gava, Marie Tosolini, et al.
Cancers
|
January 27, 2021
Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
Anne Gomez-Brouchet, Julia Gilhodes, Nathalie Van Acker, et al.
Blood
|
February 18, 2010
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study
Etienne Coyaud, Stephanie Struski, Nais Prade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2017
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Myron S Czuczman, Marek Trněný, Andrew Davies, et al.
Page
of 15